AtriCure upgraded to ‘Buy’ by Roth Capital, target price raised 30%
Investment bank Roth Capital Partners has upgraded shares of AtriCure Inc. (NASDAQ:ATRC) to "Buy" and raised its target price by nearly 30 percent.
Investment bank Roth Capital Partners has upgraded shares of AtriCure Inc. (NASDAQ:ATRC) to "Buy" and raised its target price by nearly 30 percent.